<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02691416</url>
  </required_header>
  <id_info>
    <org_study_id>ThirdCCCTianjin</org_study_id>
    <nct_id>NCT02691416</nct_id>
  </id_info>
  <brief_title>Role of Propofol Postconditioning on Oxidative Stress and Cognitive Function</brief_title>
  <official_title>Role of Propofol Postconditioning on Oxidative Stress and Cognitive Function in Patients Undergoing Intracranial Aneurysm Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Third Central Clinical College of Tianjin Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Third Central Clinical College of Tianjin Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to evaluate differences between propofol postconditioning and
      sevoflurane anesthesia in the intracranial aneurysm surgery about antioxidant effect.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      intracranial aneurysm surgery may lead to regional ischemic reperfusion injury. Propofol, as
      an antioxidative phenol, has been demonstrated that mitigate the brain I/R in rats.

      As for sevoflurane, some investigation indicated that sevoflurane is able to reduce oxidative
      stress in cell(except neuronal cell lines ) and rodent models, but the antioxidant effect did
      not found in human minor incision surgeries, furthermore, oxidative stress was raised in the
      major surgeries including orthopedic surgeries, hysterectomy, cholecystectomy, and
      thoracotomy
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2014</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evidences of Clinically Definite Oxidative Stress Confirmed by ELISA Kit</measure>
    <time_frame>before induction,after clamping removal ,operation ending ,1,3,7days post surgery</time_frame>
    <description>Evidences of clinically definite oxidative stress :Superoxide dismutase activity, Hydroxyl radical</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evidences of Clinically Definite Oxidative Stress Confirmed by ELISA</measure>
    <time_frame>before induction, after clamping removal,operation ending,1,3,7days post surgery</time_frame>
    <description>Evidences of clinically definite oxidative stress:8-isoprostane,as a reliable biomarkers of lipid peroxidation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evidences of Clinically Definite Oxidative Stress:Micronuclei</measure>
    <time_frame>before induction,clamping removal ,operation ending,1,3,7days post surgery</time_frame>
    <description>Evidences of clinically definite oxidative stress:micronuclei confirmed by Cytokinesis-block Micronucleus Test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evidences of Clinically Definite Oxidative Stress Confirmed by High Performance Liquid Chromatography</measure>
    <time_frame>before induction,after clamping removal ,operation ending ,1,3,7days post surgery</time_frame>
    <description>Evidences of clinically definite oxidative stress :α- tocopherol,γ- tocopherol which was used to assess the antioxidant defense.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evidences of Clinically Definite Oxidative Stress: Nuclear Buds</measure>
    <time_frame>before induction,clamping removal ,operation ending,1,3,7days post surgery</time_frame>
    <description>Evidences of clinically definite oxidative stress:nuclear buds Confirmed by Cytokinesis-block Micronucleus Test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evidences of Clinically Definite Oxidative Stress: Nucleoplasmic Bridges</measure>
    <time_frame>before induction,clamping removal ,operation ending,1,3,7days post surgery</time_frame>
    <description>Evidences of clinically definite oxidative stress: nucleoplasmic bridges confirmed by Cytokinesis-block Micronucleus Test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mini Mental State Examination (MMSE)</measure>
    <time_frame>before induction,1,3,7days post surgery</time_frame>
    <description>A questionnaires is used to assess the cognitive function of patients in clinical,the total range was 0-30,and 27-30 were considered as normal value,&lt;27 were considered as recognitive dysfunction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Montreal Cognitive Assessment (MoCA)</measure>
    <time_frame>before induction,1,3,7days post surgery</time_frame>
    <description>A questionnaires is used to assess the cognitive function of patients in clinical,the total range was 0-30,and 27-30 were considered as normal value,&lt;27 were considered as recognitive dysfunction.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Cerebral Arterial Aneurysm</condition>
  <arm_group>
    <arm_group_label>propofol postconditioning</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1.2mg/L propofol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sevoflurane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.5%-2% sevoflurane</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propofol postconditioning</intervention_name>
    <description>administrated Target Controlled Infusion(TCI) of propofol (Cp 1.2ug/ml) and decreased sevoflurane with a Bispectral index (BIS) value of 40-60 to maintain anesthesia after clamp removal</description>
    <arm_group_label>propofol postconditioning</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sevoflurane</intervention_name>
    <description>0.5%-2% sevoflurane with BIS 40-60</description>
    <arm_group_label>propofol postconditioning</arm_group_label>
    <arm_group_label>sevoflurane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis intracranial aneurysm surgery ,

          -  American Society of Anesthesiologists (ASA)Ⅰ-Ⅱ.

        Exclusion Criteria:

          -  severe hepatic and renal dysfunction

          -  coagulation disorder

          -  taking antioxidant perioperative period
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Haiyun Wang</last_name>
    <role>Study Director</role>
    <affiliation>The Third Central Clinical College of Tianjin Medical University</affiliation>
  </overall_official>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 3, 2016</study_first_submitted>
  <study_first_submitted_qc>February 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2016</study_first_posted>
  <results_first_submitted>April 7, 2016</results_first_submitted>
  <results_first_submitted_qc>July 21, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 2, 2016</results_first_posted>
  <last_update_submitted>June 10, 2017</last_update_submitted>
  <last_update_submitted_qc>June 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Intracranial Aneurysm</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>From July 2014 to January 2016, patients who were undergoing intracranial aneurysm surgery at hospital and consistent with the criterion of American Society of Anesthesiologists (ASA)Ⅰ-Ⅱ,but without severe hepatic and renal dysfunction, coagulation disorder were recruited.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Propofol Postconditioning</title>
          <description>Group propofol postconditioning was administrated TCI of propofol (Cp 1.2ug/ml) and decreased sevoflurane concentration with a BIS value of 40-60 to maintain anesthesia after clamp removal immediately.</description>
        </group>
        <group group_id="P2">
          <title>Sevoflurane</title>
          <description>0.5%-2% sevoflurane
sevoflurane: 0.5%-2% sevoflurane with BIS 40-60</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Propofol Postconditioning</title>
          <description>1.2ug/ml propofol Group propofol postconditioning was administrated TCI of propofol (Cp 1.2ug/ml) and decreased sevoflurane concentration with a BIS value of 40-60 to maintain anesthesia after clamp removal immediately.</description>
        </group>
        <group group_id="B2">
          <title>Sevoflurane</title>
          <description>0.5%-2% sevoflurane
sevoflurane: 0.5%-2% sevoflurane with BIS 40-60</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="30"/>
            <count group_id="B2" value="30"/>
            <count group_id="B3" value="60"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>China</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Evidences of Clinically Definite Oxidative Stress Confirmed by ELISA Kit</title>
        <description>Evidences of clinically definite oxidative stress :Superoxide dismutase activity, Hydroxyl radical</description>
        <time_frame>before induction,after clamping removal ,operation ending ,1,3,7days post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol Postconditioning</title>
            <description>1.2ug/ml propofol
propofol: Group propofol postconditioning was administrated TCI of propofol (Cp 1.2ug/ml) and decreased sevoflurane concentration with a BIS value of 40-60 to maintain anesthesia after clamp removal immediately.</description>
          </group>
          <group group_id="O2">
            <title>Sevoflurane</title>
            <description>0.5%-2% sevoflurane
sevoflurane: 0.5%-2% sevoflurane with BIS 40-60</description>
          </group>
        </group_list>
        <measure>
          <title>Evidences of Clinically Definite Oxidative Stress Confirmed by ELISA Kit</title>
          <description>Evidences of clinically definite oxidative stress :Superoxide dismutase activity, Hydroxyl radical</description>
          <units>U/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Superoxide dismutase activity of before induction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.87" spread="23.15"/>
                    <measurement group_id="O2" value="74.02" spread="21.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Superoxide dismutase activity of clamping removal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.10" spread="16.52"/>
                    <measurement group_id="O2" value="65.91" spread="16.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Superoxide dismutase activity of operation ending</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.74" spread="16.50"/>
                    <measurement group_id="O2" value="51.58" spread="14.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Superoxide dismutase activity of 1days postsurgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.80" spread="16.56"/>
                    <measurement group_id="O2" value="52.82" spread="14.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Superoxide dismutase activity of 3days postsurgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.27" spread="16.66"/>
                    <measurement group_id="O2" value="57.35" spread="17.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Superoxide dismutase activity of 7days postsurgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.02" spread="16.95"/>
                    <measurement group_id="O2" value="59.33" spread="17.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxyl radical of before induction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.30" spread="6.46"/>
                    <measurement group_id="O2" value="6.60" spread="6.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxyl radical of clamping removal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.80" spread="4.42"/>
                    <measurement group_id="O2" value="16.22" spread="5.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxyl radical of operation ending</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.54" spread="4.32"/>
                    <measurement group_id="O2" value="15.29" spread="5.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxyl radical of 1days post surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.32" spread="4.61"/>
                    <measurement group_id="O2" value="13.65" spread="5.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxyl radical of 3days post surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.05" spread="4.80"/>
                    <measurement group_id="O2" value="12.46" spread="5.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hydroxyl radical of 7days post surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.33" spread="5.57"/>
                    <measurement group_id="O2" value="10.32" spread="5.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Evidences of Clinically Definite Oxidative Stress Confirmed by ELISA</title>
        <description>Evidences of clinically definite oxidative stress:8-isoprostane,as a reliable biomarkers of lipid peroxidation</description>
        <time_frame>before induction, after clamping removal,operation ending,1,3,7days post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol Postconditioning</title>
            <description>1.2ug/mL propofol
propofol: Group propofol postconditioning was administrated TCI of propofol (Cp 1.2ug/ml) and decreased sevoflurane concentration with a BIS value of 40-60 to maintain anesthesia after clamp removal immediately.</description>
          </group>
          <group group_id="O2">
            <title>Sevoflurane</title>
            <description>0.5%-2% sevoflurane
sevoflurane: 0.5%-2% sevoflurane with BIS 40-60</description>
          </group>
        </group_list>
        <measure>
          <title>Evidences of Clinically Definite Oxidative Stress Confirmed by ELISA</title>
          <description>Evidences of clinically definite oxidative stress:8-isoprostane,as a reliable biomarkers of lipid peroxidation</description>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>8-isoprostane of before induction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.15" spread="0.14"/>
                    <measurement group_id="O2" value="1.18" spread="0.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8-isoprostane of clamping removal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.19" spread="0.15"/>
                    <measurement group_id="O2" value="1.22" spread="0.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8-isoprostane of operation ending</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.54" spread="0.16"/>
                    <measurement group_id="O2" value="1.70" spread="0.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8-isoprostane of 1days post surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.51" spread="0.16"/>
                    <measurement group_id="O2" value="1.64" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8-isoprostane of 3days post surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.48" spread="0.17"/>
                    <measurement group_id="O2" value="1.60" spread="0.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8-isoprostane of 7days post surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.38" spread="0.18"/>
                    <measurement group_id="O2" value="1.49" spread="0.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Evidences of Clinically Definite Oxidative Stress:Micronuclei</title>
        <description>Evidences of clinically definite oxidative stress:micronuclei confirmed by Cytokinesis-block Micronucleus Test</description>
        <time_frame>before induction,clamping removal ,operation ending,1,3,7days post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol Postconditioning</title>
            <description>1.2ug/mL propofol
propofol: Group propofol postconditioning was administrated TCI of propofol (Cp 1.2ug/ml) and decreased sevoflurane concentration with a BIS value of 40-60 to maintain anesthesia after clamp removal immediately</description>
          </group>
          <group group_id="O2">
            <title>Sevoflurane</title>
            <description>0.5%-2% sevoflurane
sevoflurane: 0.5%-2% sevoflurane with BIS 40-60</description>
          </group>
        </group_list>
        <measure>
          <title>Evidences of Clinically Definite Oxidative Stress:Micronuclei</title>
          <description>Evidences of clinically definite oxidative stress:micronuclei confirmed by Cytokinesis-block Micronucleus Test</description>
          <units>number of micronuclei/1000 BN cells</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>micronuclei of before induction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="185.83" spread="21.69"/>
                    <measurement group_id="O2" value="186.40" spread="19.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>micronuclei of clamping removal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="194.57" spread="25.27"/>
                    <measurement group_id="O2" value="195.73" spread="24.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>micronuclei of operation ending</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="230.77" spread="25.00"/>
                    <measurement group_id="O2" value="375.87" spread="30.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>micronuclei of 1days post surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="278.73" spread="30.86"/>
                    <measurement group_id="O2" value="402.27" spread="27.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>micronuclei of 3days post surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="248.43" spread="30.88"/>
                    <measurement group_id="O2" value="338.00" spread="30.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>micronuclei of 7days post surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="201.33" spread="28.98"/>
                    <measurement group_id="O2" value="243.63" spread="29.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Evidences of Clinically Definite Oxidative Stress Confirmed by High Performance Liquid Chromatography</title>
        <description>Evidences of clinically definite oxidative stress :α- tocopherol,γ- tocopherol which was used to assess the antioxidant defense.</description>
        <time_frame>before induction,after clamping removal ,operation ending ,1,3,7days post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol Postconditioning</title>
            <description>1.2ug/ml propofol
propofol: Group propofol postconditioning was administrated TCI of propofol (Cp 1.2ug/ml) and decreased sevoflurane concentration with a BIS value of 40-60 to maintain anesthesia after clamp removal immediately.</description>
          </group>
          <group group_id="O2">
            <title>Sevoflurane</title>
            <description>0.5%-2% sevoflurane
sevoflurane: 0.5%-2% sevoflurane with BIS 40-60</description>
          </group>
        </group_list>
        <measure>
          <title>Evidences of Clinically Definite Oxidative Stress Confirmed by High Performance Liquid Chromatography</title>
          <description>Evidences of clinically definite oxidative stress :α- tocopherol,γ- tocopherol which was used to assess the antioxidant defense.</description>
          <units>ug/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>α- tocopherol of before induction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.67" spread="1.96"/>
                    <measurement group_id="O2" value="12.22" spread="1.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>α- tocopherol of clamping removal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.13" spread="1.81"/>
                    <measurement group_id="O2" value="6.12" spread="1.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>α- tocopherol of opertaion ending</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.71" spread="1.79"/>
                    <measurement group_id="O2" value="5.91" spread="1.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>α- tocopherol of 1days post surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.97" spread="1.87"/>
                    <measurement group_id="O2" value="8.23" spread="1.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>α- tocopherol of 3days post surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.02" spread="2.06"/>
                    <measurement group_id="O2" value="9.31" spread="1.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>α- tocopherol of 7days post surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.54" spread="1.84"/>
                    <measurement group_id="O2" value="10.98" spread="1.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>γ- tocopherol of before induction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.52" spread="0.08"/>
                    <measurement group_id="O2" value="0.53" spread="0.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>γ- tocopherol of clamping removal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.59" spread="0.09"/>
                    <measurement group_id="O2" value="0.57" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>γ- tocopherol of opertaion ending</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.84" spread="0.10"/>
                    <measurement group_id="O2" value="0.75" spread="0.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>γ- tocopherol of 1days post surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.76" spread="0.11"/>
                    <measurement group_id="O2" value="0.69" spread="0.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>γ- tocopherol of 3days post surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.70" spread="0.13"/>
                    <measurement group_id="O2" value="0.62" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>γ- tocopherol of 7days post surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.68" spread="0.13"/>
                    <measurement group_id="O2" value="0.60" spread="0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Evidences of Clinically Definite Oxidative Stress: Nuclear Buds</title>
        <description>Evidences of clinically definite oxidative stress:nuclear buds Confirmed by Cytokinesis-block Micronucleus Test</description>
        <time_frame>before induction,clamping removal ,operation ending,1,3,7days post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol Postconditioning</title>
            <description>1.2ug/ml propofol
propofol: Group propofol postconditioning was administrated TCI of propofol (Cp 1.2ug/ml) and decreased sevoflurane concentration with a BIS value of 40-60 to maintain anesthesia after clamp removal immediately.</description>
          </group>
          <group group_id="O2">
            <title>Sevoflurane</title>
            <description>0.5%-2% sevoflurane
sevoflurane: 0.5%-2% sevoflurane with BIS 40-60</description>
          </group>
        </group_list>
        <measure>
          <title>Evidences of Clinically Definite Oxidative Stress: Nuclear Buds</title>
          <description>Evidences of clinically definite oxidative stress:nuclear buds Confirmed by Cytokinesis-block Micronucleus Test</description>
          <units>number of nuclear buds/1000 BN cells</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>nuclear buds of before induction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.40" spread="8.84"/>
                    <measurement group_id="O2" value="53.93" spread="9.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>nuclear buds of clamp ing removal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.33" spread="8.56"/>
                    <measurement group_id="O2" value="57.43" spread="8.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>nuclear buds of operation ending</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61.10" spread="9.16"/>
                    <measurement group_id="O2" value="62.87" spread="10.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>nuclear buds of 1days post surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.73" spread="10.38"/>
                    <measurement group_id="O2" value="65.07" spread="11.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>nuclear buds of 3days post surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.00" spread="8.31"/>
                    <measurement group_id="O2" value="61.70" spread="10.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>nuclear buds of 7days post surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.87" spread="9.56"/>
                    <measurement group_id="O2" value="55.67" spread="11.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Evidences of Clinically Definite Oxidative Stress: Nucleoplasmic Bridges</title>
        <description>Evidences of clinically definite oxidative stress: nucleoplasmic bridges confirmed by Cytokinesis-block Micronucleus Test</description>
        <time_frame>before induction,clamping removal ,operation ending,1,3,7days post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol Postconditioning</title>
            <description>1.2ug/mL propofol
propofol:Group propofol postconditioning was administrated TCI of propofol (Cp 1.2ug/ml) and decreased sevoflurane concentration with a BIS value of 40-60 to maintain anesthesia after clamp removal immediately</description>
          </group>
          <group group_id="O2">
            <title>Sevoflurane</title>
            <description>0.5%-2% sevoflurane
sevoflurane: 0.5%-2% sevoflurane with BIS 40-60</description>
          </group>
        </group_list>
        <measure>
          <title>Evidences of Clinically Definite Oxidative Stress: Nucleoplasmic Bridges</title>
          <description>Evidences of clinically definite oxidative stress: nucleoplasmic bridges confirmed by Cytokinesis-block Micronucleus Test</description>
          <units>number of nucleoplasmic bridges/1000 BN</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>nucleoplasmic bridges of before induction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.50" spread="9.92"/>
                    <measurement group_id="O2" value="68.73" spread="8.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>nucleoplasmic bridges of clamp ing removal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.77" spread="13.66"/>
                    <measurement group_id="O2" value="80.80" spread="12.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>nucleoplasmic bridges of operation ending</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.40" spread="14.08"/>
                    <measurement group_id="O2" value="96.23" spread="12.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>nucleoplasmic bridges of 1days post surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.83" spread="14.74"/>
                    <measurement group_id="O2" value="111.93" spread="11.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>nucleoplasmic bridges of 3days post surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.87" spread="11.29"/>
                    <measurement group_id="O2" value="96.37" spread="12.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>nucleoplasmic bridges of 7days post surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.20" spread="11.17"/>
                    <measurement group_id="O2" value="87.83" spread="12.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mini Mental State Examination (MMSE)</title>
        <description>A questionnaires is used to assess the cognitive function of patients in clinical,the total range was 0-30,and 27-30 were considered as normal value,&lt;27 were considered as recognitive dysfunction.</description>
        <time_frame>before induction,1,3,7days post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol Postconditioning</title>
            <description>1.2ug/mL propofol
propofol: Group propofol postconditioning was administrated TCI of propofol (Cp 1.2ug/ml) and decreased sevoflurane concentration with a BIS value of 40-60 to maintain anesthesia after clamp removal</description>
          </group>
          <group group_id="O2">
            <title>Sevoflurane</title>
            <description>0.5%-2% sevoflurane
sevoflurane: 0.5%-2% sevoflurane with BIS 40-60</description>
          </group>
        </group_list>
        <measure>
          <title>Mini Mental State Examination (MMSE)</title>
          <description>A questionnaires is used to assess the cognitive function of patients in clinical,the total range was 0-30,and 27-30 were considered as normal value,&lt;27 were considered as recognitive dysfunction.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>before induction of MMSE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.63" spread="1.43"/>
                    <measurement group_id="O2" value="27.23" spread="1.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1days post surgery of MMSE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.40" spread="1.87"/>
                    <measurement group_id="O2" value="17.73" spread="2.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 days post surgery of MMSE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.43" spread="2.18"/>
                    <measurement group_id="O2" value="20.33" spread="1.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7 days post surgery of MMSE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.00" spread="2.00"/>
                    <measurement group_id="O2" value="24.30" spread="1.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Montreal Cognitive Assessment (MoCA)</title>
        <description>A questionnaires is used to assess the cognitive function of patients in clinical,the total range was 0-30,and 27-30 were considered as normal value,&lt;27 were considered as recognitive dysfunction.</description>
        <time_frame>before induction,1,3,7days post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol Postconditioning</title>
            <description>1.2ug/mL propofol
propofol:Group propofol postconditioning was administrated TCI of propofol (Cp 1.2ug/ml) and decreased sevoflurane concentration with a BIS value of 40-60 to maintain anesthesia after clamp removal immediately</description>
          </group>
          <group group_id="O2">
            <title>Sevoflurane</title>
            <description>0.5%-2% sevoflurane
sevoflurane: 0.5%-2% sevoflurane with BIS 40-60</description>
          </group>
        </group_list>
        <measure>
          <title>Montreal Cognitive Assessment (MoCA)</title>
          <description>A questionnaires is used to assess the cognitive function of patients in clinical,the total range was 0-30,and 27-30 were considered as normal value,&lt;27 were considered as recognitive dysfunction.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>before induction of MoCA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.43" spread="2.39"/>
                    <measurement group_id="O2" value="19.87" spread="2.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1days post surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.53" spread="2.58"/>
                    <measurement group_id="O2" value="19.20" spread="2.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3days post surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.53" spread="2.68"/>
                    <measurement group_id="O2" value="20.80" spread="2.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7days post surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.20" spread="2.27"/>
                    <measurement group_id="O2" value="23.10" spread="2.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>7days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Propofol Postconditioning</title>
          <description>1.2ug/mL propofol
propofol:Group propofol postconditioning was administrated TCI of propofol (Cp 1.2ug/ml) and decreased sevoflurane concentration with a BIS value of 40-60 to maintain anesthesia after clamp removal immediately.</description>
        </group>
        <group group_id="E2">
          <title>Sevoflurane</title>
          <description>0.5%-2% sevoflurane
sevoflurane: 0.5%-2% sevoflurane with BIS 40-60</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr.Haiyun Wang</name_or_title>
      <organization>The Third Central Clinical College of Tianjin Medical University, Tianjin the Third Central Hospital</organization>
      <phone>13752211206</phone>
      <email>why819@126.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

